Top Markets
#1 Black Phoenix Black Phoenix +734.39%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#3 MetaDAO MetaDAO +22.54%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.17%
#5 Verus Coin Verus Coin +14.03%
#6 Akedo Akedo +8.97%
#7 Biconomy Biconomy +8.23%
#8 Tokamak Network Tokamak Network +7.07%
#9 XYO Network XYO Network +6.81%
#10 Tornado Cash Tornado Cash +5.67%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Beijing Tiantan Biological Products Co., Ltd. Beijing Tiantan Biological Products Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

600161
Rank in Stocks #4525
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Share Price
$1.81
Last synced: 2026-08-26
Market Cap
$3.59B
Change (1 day)
1.62%
Change (1 year)
-35.81%
Country
CN
Trade Beijing Tiantan Biological Products Co., Ltd. (600161)

Category

Healthcare
Operating Margin for Beijing Tiantan Biological Products Co., Ltd. (600161)
Operating Margin as of 2026 TTM: 0.00%
According to Beijing Tiantan Biological Products Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Beijing Tiantan Biological Products Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.